Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frizzell, R. T.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frizzell, R. T.
Right arrow Articles by Cherrington, A. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 37, Issue 11 1531-1541, Copyright © 1988 by American Diabetes Association


ARTICLES

Stimulation of glucose production through hormone secretion and other mechanisms during insulin-induced hypoglycemia

RT Frizzell, GK Hendrick, LL Brown, DB Lacy, EP Donahue, RK Carr, PE Williams, AF Parlow, RW Stevenson and AD Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232.

To assess the role of counterregulatory hormones per se in the response to continuous insulin infusion, overnight-fasted dogs were given 5 mU.kg-1.min-1 insulin intraportally either alone (INS, n = 5), with glucose to maintain euglycemia (INS + GLU, n = 5), or with glucose and hormone replacement [i.e., glucagon, epinephrine, norepinephrine, and cortisol infusions (INS + GLU + HR, n = 6)]. The increases in counterregulatory hormones that occurred during insulin-induced hypoglycemia were simulated in the latter group. In this way, it was possible to separate the effects of hypoglycemia per se from those due to the associated counterregulatory hormone response. Glycogenolysis and gluconeogenesis were measured with a combination of tracer ([ 3-3H]glucose and [U-14C]alanine) and hepatic arteriovenous (AV) difference techniques during a 40-min control and a 180-min experimental period. Insulin levels increased similarly in all groups (to congruent to 250 microU/ml), whereas plasma glucose levels decreased in INS (115 +/- 3 to 41 +/- 3 mg/dl; P less than .05) and rose slightly in both INS + GLU (108 +/- 2 to 115 +/- 4 mg/dl; P less than .05) and INS + GLU + HR (111 +/- 3 to 120 +/- 3 mg/dl; P less than .05) due to glucose infusion. Glucagon, epinephrine, norepinephrine, and cortisol were replaced in INS + GLU + HR so that the increments in their levels were 102 +/- 6, 106 +/- 14, 117 +/- 9, and 124 +/- 37%, respectively, of their increments in INS. At no time was there a significant difference between the hormone levels in INS and INS + GLU + HR. The rise in the counterregulatory hormones per se accounted for only half (53 +/- 9% by the AV difference method and 54 +/- 10% by tracer method) of the glucose production associated with hypoglycemia resulting from insulin infusion. The rate and efficiency of alanine conversion to glucose in the hormone-replacement studies were only 29 +/- 10 and 50 +/- 27% of what occurred during hypoglycemia induced by insulin infusion. In conclusion, the counterregulatory hormones alone (i.e., without accompanying hypoglycemia) can account for only 50% of the glucose production that is present during insulin-induced hypoglycemia. The remaining 50%, therefore, must result from effects of hypoglycemia other than its ability to trigger hormone release.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. D. Cherrington
Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia
Diabetes, May 1, 2008; 57(5): 1158 - 1159.
[Full Text] [PDF]


Home page
J. Nutr.Home page
C. Blouet, F. Mariotti, D. Azzout-Marniche, C. Bos, V. Mathe, D. Tome, and J.-F. Huneau
The Reduced Energy Intake of Rats Fed a High-Protein Low-Carbohydrate Diet Explains the Lower Fat Deposition, but Macronutrient Substitution Accounts for the Improved Glycemic Control
J. Nutr., July 1, 2006; 136(7): 1849 - 1854.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Galassetti, S. Mann, D. Tate, R. A. Neill, D. H. Wasserman, and S. N. Davis
Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise
J Appl Physiol, July 1, 2001; 91(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. A. Jackson, S. Cardin, C. S. Coffey, D. W. Neal, E. J. Allen, A. R. Penaloza, W. L. Snead, and A. D. Cherrington
Effect of hepatic denervation on the counterregulatory response to insulin-induced hypoglycemia in the dog
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1249 - E1257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. A. Jackson, M. J. Pagliassotti, M. Shiota, D. W. Neal, S. Cardin, and A. D. Cherrington
Effects of vagal blockade on the counterregulatory response to insulin-induced hypoglycemia in the dog
Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1178 - E1188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1988 by the American Diabetes Association.